Targeting ARID1A-mutated gastric cancer cells with synthetic lethal approaches

被引：0
|
作者：
Fang, Menghan
Lin, Youfen
Xue, Chaorong
Sheng, Kaiqin
Guo, Zegeng
Han, Yuting
Lin, Hanbin
Wu, Yuecheng
Howell, Stephen B.
Lin, Xu
Lin, Xinjian
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3221
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3221
引用
收藏
页数：2
相关论文
共 50 条
  • [21] DNA methylating drug temozolomide sensitizes ARID1A-mutated tumors to PARP inhibitors
    Yu, Zheng-Cheng
    Li, Tianhe
    Yamada, Shigehiro
    Shih, Ie-Ming
    Gaillard, Stephanie
    Wang, Tian-Li
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S8 - S9
  • [22] COMBINATIONAL TARGETING OF HDAC6 AND PD-1/PD-L1 IMMUNE CHECKPOINT IN ARID1A-MUTATED OVARIAN CANCERS
    Fatkhutdinov, Nail
    Fukumoto, Takeshi
    Zhang, Rugang
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 158 - 158
  • [23] Targeting synthetic lethal paralogs in cancer
    Ryan, Colm J.
    Mehta, Ishan
    Kebabci, Narod
    Adams, David J.
    TRENDS IN CANCER, 2023, 9 (05) : 397 - 409
  • [24] Targeting cancer cells with mutated KRAS with krasin, a novel synthetic cycloheptapeptide
    Sheikhnejad, R.
    Tahoori, F.
    Shokri, B.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S208 - S208
  • [25] Synthetic lethal approaches to cancer therapy
    Ashworth, A.
    EJC SUPPLEMENTS, 2010, 8 (05): : 88 - 88
  • [26] Synthetic Lethal Approaches to Cancer Therapy
    Ashworth, A.
    CANCER RESEARCH, 2010, 70
  • [27] Synthetic lethal approaches to targeting Ras mutant cancers
    Downward, Julian
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [28] SWI/SNF catalytic subunits’ switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells
    Shuai Wu
    Nail Fatkhutdinov
    Takeshi Fukumoto
    Benjamin G. Bitler
    Pyoung Hwa Park
    Andrew V. Kossenkov
    Marco Trizzino
    Hsin-Yao Tang
    Lin Zhang
    Alessandro Gardini
    David W. Speicher
    Rugang Zhang
    Nature Communications, 9
  • [29] SWI/SNF catalytic subunits' switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells
    Wu, Shuai
    Fatkhutdinov, Nail
    Fukumoto, Takeshi
    Bitler, Benjamin G.
    Park, Pyoung Hwa
    Kossenkov, Andrew V.
    Trizzino, Marco
    Tang, Hsin-Yao
    Zhang, Lin
    Gardini, Alessandro
    Speicher, David W.
    Zhang, Rugang
    NATURE COMMUNICATIONS, 2018, 9
  • [30] CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma
    Kawahara, Naoki
    Yamada, Yuki
    Kobayashi, Hiroshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
12345